Stories

A shift in the tobacco harm reduction debate is increasingly being described as the “rise of the pragmatists.” Rather than focusing on ideology, this perspective emphasizes real-world outcomes and what actually works in reducing smoking-related harm. It aligns with a broader pragmatist approach, where ideas are judged by their practical consequences rather than theoretical positions. Supporters argue that policies should be guided by evidence, consumer behavior, and measurable health impacts. This approach challenges more rigid frameworks that prioritize abstinence or precaution over harm reduction. The discussion reflects a growing divide in public health between principle-driven and outcome-driven strategies.

A growing body of scientific research is exploring the potential role of smoke-free nicotine products in reducing global smoking rates. Recent analysis suggests that wider adoption of alternatives such as e-cigarettes could accelerate progress toward ambitious public health targets. In particular, experts highlight the possibility of reducing smoking prevalence to below 5% worldwide within the coming decades. The argument is based on the premise that shifting smokers away from combustible tobacco can significantly lower disease burden. Researchers emphasise that integrating harm reduction strategies into policy could complement traditional tobacco control measures.

A study analyzed heated tobacco product (HTP) user estimates globally from 2014 to 2024. Two estimation approaches revealed an estimated 48.9 million users in 2024, potentially reaching 78.7 million. The data primarily relied on company disclosures, with an alternative approach using standardised consumption assumptions. A survey-based estimate across 35 countries reported 21.8 million users. Although uncertainties exist due to conversion assumptions and definitional disparities, the findings illustrate consistent growth trends and highlight the need for standardized surveillance methods in tracking the evolving landscape of tobacco and nicotine consumption globally.

Recent scientific research continues to examine patterns of vaping use and their implications for public health. Large-scale international data suggest that while experimentation with e-cigarettes among young people is relatively common, regular or frequent use remains significantly lower. This distinction between occasional and habitual use is increasingly important in shaping how nicotine trends are interpreted. Researchers emphasize that most adolescent vaping appears to be infrequent rather than sustained behavior. At the same time, the findings highlight the need for targeted policies, such as age restrictions and product regulation, to prevent uptake among youth. The study contributes to a broader evidence base informing ongoing debates about vaping, youth behavior, and appropriate regulatory responses.

Vaping has overtaken smoking in Great Britain for the first time, marking a significant shift in nicotine use patterns. Recent data show that around 10% of adults now vape, compared to 9.1% who smoke, reflecting a long-term decline in cigarette use. In absolute numbers, this translates to approximately 5.4 million vapers versus 4.9 million smokers. Experts describe the crossover as a major milestone in tobacco control, pointing to substitution from smoking rather than new nicotine uptake. The trend is increasingly shaping debates on harm reduction and future nicotine policy across Europe.

A Dutch study found that after a flavor ban, 40% of vapers reduced usage, with 22% quitting. However, 6% started smoking due to the ban, while 10.8% used alternative products more, mainly cigarettes. Most quitters didn't switch products. Critics argue that reduced vaping led to increased smoking, with 16.3% either smoking more or starting due to the ban. Concerns were raised about how dual users were accounted for. Cross-border purchases were common post-ban. The study points to unintended consequences and raises questions about the overall impact of flavor bans. Policymakers may need to consider potential outcomes when implementing such regulations.

The European Commission's report on smoking and nicotine use is criticized for biased authorship and a negative stance on tobacco harm reduction, despite the decline in smoking rates attributed to EU regulations. Concerns about the impact on future policy are raised, with advocates highlighting the benefits of safer nicotine products like vapes in reducing smoking rates. The report disregards scientific evidence supporting harm reduction and contains flaws in methodology, possibly influenced by authors linked to anti-vaping interests. Critics argue that the Commission is neglecting public health by not recognizing harm reduction as a valuable tool in smoking cessation. EU policymakers are urged to reconsider their approach to nicotine alternatives.

One of the world’s leading harm reduction advocates sees disaster unfolding in Australia. Sky-high tobacco taxes and sweeping restrictions on nicotine vaping were meant to reduce harm—but instead, they’ve fueled a booming illicit market, siphoned billions in public revenue, and triggered a wave of violence tied to organized crime. In this GFN Interviews, Dr. Alex Wodak explains how Australia’s approach has veered into “quasi prohibition,” driving demand into the black market and overwhelming enforcement.

A new analysis from Prohibition Does Not Work examines the impact of the Netherlands’ ban on non-tobacco vape flavours. The findings suggest that the policy has not achieved its intended goal of reducing youth nicotine use. Instead, reported data indicate increases in youth vaping alongside a rise in cigarette consumption. The report also highlights a significant shift of consumers from the legal market to illicit supply channels. These outcomes are presented as evidence that prohibition-style regulation may produce unintended public health consequences.

Debates over the EVALI outbreak and its implications for vaping policy continue to resurface in public health discussions. Critics argue that regulatory and media responses to the 2019 lung injury cases contributed to widespread confusion about the actual causes of the illness. Evidence from investigations by U.S. health authorities indicated that most cases were linked to illicit THC products containing vitamin E acetate rather than nicotine vaping. Despite this, some analysts believe that the CDC’s communication approach had lasting effects on public perception of all vaping products. The issue remains central to ongoing disputes about how public health agencies should communicate risks related to emerging nicotine technologies.